|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
4R00CA207848-03
|
$19,074
|
|
WARREN ANDERSEN, SHANEDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
|
2R42CA206744-02A1
|
$665,919
|
|
MCCABE, AARON
|
MINNETRONIX, INC.
|
|
Using Microfluidic Single Cell Culture to Characterize Cancer Cell Asymmetric Division
|
7R01CA203810-02
|
$412,307
|
|
BUCKANOVICH, RONALD
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S3
|
$250,001
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$303,429
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Transient anti-BCMA CAR T-cells for Treatment of Multiple Myeloma
|
1R43CA221432-01A1
|
$299,042
|
|
STEWART, CHARLES
|
CARTESIAN THERAPEUTICS, INC.
|
|
Therapeutic peptide for hepatocellular carcinoma
|
1R43CA232947-01
|
$299,983
|
|
PANDEY, NIRANJAN
|
ASCLEPIX THERAPEUTICS, LLC
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$192,605
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$7,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$6,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$7,385
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$1,751
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Hemopurifier Device for Targeted Removal of Breast Cancer Exosomes from the Blood Circulation
|
1R43CA232977-01
|
$298,444
|
|
MARLEAU, ANNETTE
|
AETHLON MEDICAL, INC.
|
|
The Connie Wofsy Womens HIV Study
|
3U01AI034989-24S1
|
$138,634
|
|
TIEN, PHYLLIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$119
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting galectin-3 to overcome drug resistance in metastatic prostate cancer therapy
|
1R43CA228813-01A1
|
$300,000
|
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
Supine Breast MRI Standardization for Breast Cancer Locator
|
1R44CA232862-01
|
$221,343
|
|
KRISHNASWAMY, VENKATARAMANAN
|
CAIRNSURGICAL, INC.
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S5
|
$158,571
|
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Specialist in Multi-Scale Molecular Imaging of Tumor Environments
|
1R50CA221807-01A1
|
$196,387
|
|
LUKER, KATHRYN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Spatiotemporal Gene Regulation and KSHV Replication
|
1R01CA225266-01A1
|
$359,138
|
|
IZUMIYA, YOSHIHIRO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Software for Efficient Estimation of the Cox Model With Interval-Censored Data
|
1R43CA233159-01
|
$146,583
|
|
MARCHENKO, YULIA
|
STATACORP, LP
|
|
Site-Specific Incorporation of Phosphorylation Modifications on the SNAP-Tide High Density Peptide Array
|
1R43CA232913-01
|
$222,678
|
|
OZERS, MARY
|
PROTEOVISTA, LLC
|
|
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance
|
1R44CA224505-01A1
|
$224,633
|
|
ZHOU, JING
|
ISOPLEXIS, INC.
|
|
Selection and preclinical development of a bacteria-targeting, non-antibiotic lead candidate to improve cancer chemotherapy outcomes
|
1R44CA233157-01
|
$300,000
|
|
PETERSON, WARD
|
SYMBERIX, INC.
|
|
Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
|
4R00CA197640-03
|
$249,000
|
|
WANG, XIAOFENG
|
DARTMOUTH COLLEGE
|
|
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
|
5R01CA219013-02
|
$586,471
|
$586,471
|
KALAPURAKAL, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Recombinant TIL Cell Therapy for Salvage Solid Tumor Patients
|
1R43CA232942-01
|
$300,000
|
|
SPINDLER, MATTHEW
|
GIGAMUNE, INC.
|
|
Rapid, quantitative and affordable point-of-care diagnostics for oral and oropharyngeal cancer
|
1R43CA228815-01A1
|
$299,917
|
|
BRAND, CHRISTIAN
|
SUMMIT BIOMEDICAL IMAGING, LLC
|
|
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
|
1R44CA233143-01
|
$218,588
|
|
LAMPI HERMANSON, DAVID
|
B-MOGEN BIOTECHNOLOGIES, INC.
|
|
Randomized controlled trial of an implementation science tool to increase cervical cancer screening in Mombasa, Kenya
|
1K08CA228761-01A1
|
$188,892
|
|
EASTMENT, MCKENNA
|
UNIVERSITY OF WASHINGTON
|
|
Pre-IND development of CBT-15 monoclonal antibody therapy against renal cell cancer
|
1R44CA228895-01A1
|
$298,835
|
|
SUREBAN, SRIPATHI
|
COARE HOLDINGS, INC.
|
|
Parallel and high throughput isolation of cancer cell derived extracellular vesicles
|
1R43CA232848-01
|
$239,138
|
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
|
Overcoming anti-PD-1 resistance by systemic delivery of an oncolytic adenovirus that targets TGF-beta
|
1R41CA224504-01A1
|
$299,956
|
|
SETH, PREM
|
MULTIVIR, INC.
|
|
Optimizing health related quality of life measurement in adolescent and young adult oncology: A PROMISing solution
|
5R01CA218398-02
|
$486,468
|
$486,468
|
SALSMAN, JOHN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
|
2R44CA203455-02A1
|
$996,232
|
|
SMITH, JENNIFER
|
PRECYTE, INC.
|
|
Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer
|
1K08CA234333-01
|
$250,514
|
$250,514
|
RAUH-HAIN, JOSE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Novel SCD1 inhibitors for treatment of cancer
|
2R42CA195946-02A1
|
$763,181
|
|
COPLAND, JOHN
|
MODULATION THERAPEUTICS, INC.
|
|
Novel Immuno-oncology Strategy for Targeted Cytotoxic Lymphocyte Activation
|
1R41CA224520-01A1
|
$288,105
|
|
KRUPNICK, ALEXANDER
|
COURIER THERAPEUTICS, INC.
|
|
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
|
1R01CA232845-01
|
$630,136
|
|
IZUMIYA, YOSHIHIRO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S1
|
$60,000
|
$600
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S2
|
$86,294
|
$863
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S3
|
$185,151
|
$1,852
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-20S4
|
$75,701
|
$757
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-20
|
$2,990,966
|
$29,910
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Military Cohort Study
|
ZIA CP010226 10693
|
$275,177
|
$137,589
|
Hoover, Robert
|
DCEG (NCI)
|
|
MICCAI 2018 - 21th International Conference on Medical Image Computing and Computer Assisted Intervention
|
1R13CA225202-01A1
|
$5,000
|
|
KONTOS, DESPINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
MHC Liver Cancer Study
|
ZIA CP010158 10532
|
$30,875
|
$6,175
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-10S1
|
$249,843
|
|
LEONE, GUSTAVO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Liver Cancer Pooling Project
|
ZIA CP010158 10496
|
$74,778
|
$14,956
|
McGlynn, Katherine
|
DCEG (NCI)
|
Total relevant funding to Contraception and Reproduction Research for this search: $3,842,253
|